The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys

R J Vermeulen, B Drukarch, M C Sahadat, C Goosen, E C Wolters, J C Stoof

Research output: Contribution to journalArticleAcademicpeer-review

38 Citations (Scopus)


The alleged selective, high efficacy dopamine D1 receptor agonist, SKF 81297 (0.05-0.3 mg/kg i.m.), induced rotational behaviour away from the lesion and stimulated use of the dominant right hand in unilaterally (left side) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned rhesus monkeys (Macaca mulatta). The effects of SKF 81297 were completely blocked by the dopamine D1 receptor antagonist, SCH 23390 (0.05 mg/kg), but not by the dopamine D2 receptor antagonist, remoxipride (1 mg/kg), and were similar to those induced by the selective dopamine D2 agonist, LY 171555 (0.01 mg/kg). These results suggest a functional stimulatory role for the dopamine D1 receptor on motor behaviour in a non-human primate model of Parkinson's disease when stimulated with a high efficacy selective dopamine D1 receptor agonist.

Original languageEnglish
Pages (from-to)143-7
Number of pages5
JournalEuropean journal of pharmacology
Issue number1
Publication statusPublished - 22 Apr 1993


  • Analysis of Variance
  • Animals
  • Benzazepines
  • Disease Models, Animal
  • Dopamine Agents
  • Ergolines
  • Journal Article
  • MPTP Poisoning
  • Macaca mulatta
  • Male
  • Motor Activity
  • Parkinson Disease
  • Quinpirole
  • Remoxipride
  • Research Support, Non-U.S. Gov't

Cite this